Stay updated on Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Sign up to get notified when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.

Latest updates to the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page
- Check4 days agoChange DetectedAdded a related topic term, Severe myoclonic epilepsy in infancy, to the page's topics section.SummaryDifference0.2%

- Check11 days agoChange DetectedDravet syndrome was removed from the conditions list on the study page, along with related references to that condition.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing Revision: v3.4.3.SummaryDifference0.2%

- Check25 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check47 days agoChange DetectedThe new screenshot shows no notable differences from the old version. All sections, text, and layout appear the same.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows a new revision label (v3.4.2) and removal of a site-wide funding/status notice, with no changes to trial details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.